is PDRN a peptide? salmon DNA vs GHK-Cu, explained
a reader asked if PDRN (the "salmon DNA" skin injectable trending in K-beauty) is a peptide. short answer: no. here is what it actually is, how it compares to GHK-Cu copper peptides, and which one makes sense for your skin -- no biology degree required.
for educational purposes only. this article explains ingredient science and is not medical or dermatological advice. if you are considering an injectable treatment like Rejuran, consult a licensed dermatologist or plastic surgeon. always verify a clinic's credentials and the sourcing of any injectable product.
the short answer: PDRN is not a peptide
PDRN stands for polydeoxyribonucleotide. that is a long word, so let us break it apart. "poly" means many, "deoxyribonucleotide" means the chemical unit that makes up DNA. so PDRN is literally many DNA units linked together in a chain. a peptide is a different kind of chain -- it is made of amino acids, the building blocks of proteins. same idea (a chain of small pieces), different pieces.
think of it like language. both English and Spanish are languages, but they use different alphabets and different grammar. peptides and PDRN are both molecular chains, but they speak different chemical alphabets. your skin cells happen to understand both.
the confusion makes sense. PDRN is often sold under names like Rejuran, Plinest, and Mastelli, and it is marketed alongside peptides on skincare websites. but the molecules are chemically distinct. the purification process for PDRN actually removes any residual peptides on purpose, because leftover protein fragments could trigger an allergic reaction in the skin [1].
so what is PDRN actually made of?
PDRN is fragmented DNA that comes mostly from the sperm cells of salmon trout or chum salmon. yes -- the "salmon DNA" headlines are accurate. the manufacturer takes raw fish DNA, chops it into shorter pieces using enzymes (enzymes are just tiny molecular scissors), and then purifies those pieces until more than 95 percent of the proteins and peptides are gone. what is left behind is a clean mixture of DNA fragments between 50 and 1500 kilodaltons in size [2].
a kilodalton is just a unit of weight for very small things (1 dalton is roughly the weight of one hydrogen atom, and 1 kilodalton is 1000 of those). for comparison, GHK-Cu, a well-studied copper peptide, weighs about 0.4 kilodaltons. that is a big size difference, and it matters for how each molecule gets into your skin (more on that below).
you may also see the term polynucleotide biorevitalization or just PN. that is the same basic idea as PDRN, with slightly longer DNA chains. if you see Rejuran, Plinest, or Mastelli on a clinic menu, they are all running on the same underlying mechanism. Rejuran is to PDRN what Ozempic is to semaglutide -- a brand built around the active ingredient.
what does PDRN actually do in your skin?
your skin has cells called fibroblasts. these are the workers that manufacture collagen and elastin, the two proteins that give young skin its bounce and firmness. as you age, fibroblasts slow down. wrinkles, thin skin, and slow wound healing all trace back to less-productive fibroblasts.
PDRN wakes those workers up. specifically, it binds to a receptor on the fibroblast surface called the adenosine A2A receptor. you can think of a receptor as a docking slot on the outside of the cell -- when the right molecule clicks into the slot, the cell changes what it is doing. when PDRN clicks into the A2A slot, three things happen. the fibroblast starts making more collagen, it calms inflammation around itself, and it helps grow new tiny blood vessels (which means better nutrient delivery to the skin) [3].
there is also a second mechanism that is actually kind of elegant. the DNA fragments in PDRN can be recycled by the cell through something called the salvage pathway. cells are thrifty -- rather than always building DNA components from scratch, they will reuse fragments when available. PDRN essentially hands the fibroblast a stack of pre-made parts, which frees the cell up to put more energy into making collagen and repairing itself [4].
how GHK-Cu compares -- a real peptide with different strengths
GHK-Cu is where peptides enter the conversation. the name is short for glycyl-L-histidyl-L-lysine bound to a copper ion. that literally just describes its recipe: three amino acids (glycine, histidine, lysine) linked in a tiny chain, with one atom of copper attached. the full molecule is only three amino acids long, which is why it is called a tripeptide.
GHK-Cu was first identified in human blood plasma in 1973, and it has been studied in dermatology for decades. the copper peptide works at a more fundamental level than PDRN -- instead of telling fibroblasts to produce more collagen, it goes into the cell and changes which genes are turned on or off. one study mapped GHK-Cu against over 4000 genes involved in tissue remodeling, antioxidant defense, and collagen synthesis. it nudged activity on all of those networks [5].
because GHK-Cu is so small (remember, 0.4 kilodaltons versus PDRN's 50-1500), it can actually penetrate skin from a topical serum. that is a huge practical difference. you can buy a GHK-Cu serum online for under $30 and apply it at home. PDRN, because the molecule is so much larger, has to be injected directly into the dermis (the layer of skin below the surface where fibroblasts live) to have a real effect. that means a clinic visit, a trained injector, and several hundred dollars per session.
head-to-head: what actually matters for your decision
both ingredients increase collagen production, calm inflammation, and improve skin texture over several weeks of consistent use. where they differ is how you get them in, how strong the evidence is, and how much they cost.
for evidence, PDRN has the cleaner clinical win in a specific scenario. a phase III randomized double-blind trial published in 2014 matched Rejuran injections against a leading hyaluronic acid filler for crow's feet (the fine lines near the outer eye). after 12 weeks of every-other-week treatments, the Rejuran group had greater elasticity and collagen density and measurably smaller wrinkle depth [6]. GHK-Cu does not have a head-to-head trial that direct, but it has a much larger body of general dermatology literature going back to the 1980s, plus formal gene-expression data that PDRN does not have.
for regulation, there is an asymmetry worth knowing. Rejuran injectables are not FDA approved in the United States as of April 2026 [7]. they are legal in South Korea, parts of Europe, and much of Southeast Asia, and some US clinics offer them off-label. GHK-Cu is not a regulated drug in the US at all -- it is classified as a cosmetic ingredient, which is why you can buy it on Amazon. neither status is a red flag by itself, but if you want an injectable with full FDA oversight, Rejuran is not that today.
for cost, topical GHK-Cu serum runs $20-80 per bottle and lasts roughly two months. a Rejuran treatment course in the US (where clinics offer it off-label) typically runs $500-1000 per session with 3-4 sessions recommended to see meaningful results [8]. that is a 15-to-20-times cost difference for your first year.
so which one should you consider?
honest answer: it depends on your goal, your budget, and how comfortable you are with needles. rather than guessing, the tool below walks you through the three questions that actually determine the answer. pick your main goal, how your skin behaves, and your budget range, and it will point you to PDRN, GHK-Cu, both, or neither with the reasoning spelled out.
the bigger picture: your skin cares about signaling, not labels
here is the punchline that matters more than the peptide-vs-DNA technicality. both PDRN and GHK-Cu work because they send signals to your skin cells. your skin does not know (or care) whether the signal came from a peptide, a DNA fragment, a growth factor, or a retinoid. what matters is whether the signal reaches the right cells and tells them to do something useful.
that framing is why the question "is this a peptide?" is less useful than "does this signal the thing I want?" peptides get most of the marketing because the word sounds scientific and clean. PDRN gets the hype in 2026 because it sounds exotic and novel. in terms of what actually makes skin better, both categories are part of the same bigger toolkit of cellular signaling molecules. ingredients that have been around a long time (retinoids, vitamin C, niacinamide) work through completely different signals and still get results. PDRN and GHK-Cu are not magic -- they are just well-characterized ways of nudging fibroblasts in the right direction.
if you want the full mechanism and clinical evidence for GHK-Cu, our GHK-Cu mastery course covers the 4000-gene network, the specific wound-healing pathways, and every published study on topical vs injected delivery. for the peptide side of the equation, that is the deepest reference we have.
frequently asked questions
no. PDRN (polydeoxyribonucleotide) is a chain of nucleotides -- the building blocks of DNA. a peptide is a chain of amino acids, the building blocks of proteins. they use different molecular alphabets. the purification process for PDRN specifically removes any residual peptides to prevent allergic reactions.
PDRN is made of fragmented DNA (50 to 1500 kilodaltons) extracted mainly from the sperm cells of salmon trout or chum salmon. the extraction process uses enzymes to chop the raw DNA into shorter usable pieces, then filters out more than 95 percent of any proteins and peptides to avoid immune reactions. what remains is purified deoxyribonucleotide fragments suspended in a sterile solution.
Rejuran is a brand name for a PDRN-based injectable made in South Korea. PDRN is the underlying molecule. polynucleotide biorevitalization (sometimes abbreviated PN) is the broader category name. in short, Rejuran is to PDRN what Ozempic is to semaglutide -- a brand built around the active ingredient.
no. as of april 2026, Rejuran injectable treatments are not FDA approved in the United States. they are widely used in South Korea, parts of Europe, and Southeast Asia. some US clinics still offer them off-label, but the regulatory status matters for safety oversight and insurance coverage. GHK-Cu, by contrast, is classified as a cosmetic ingredient and is sold over the counter in serums.
yes. they work on different pathways and do not compete. PDRN activates an adenosine A2A receptor (think of it as a specific docking slot on the cell surface) while GHK-Cu modulates thousands of genes directly inside the cell. if you are using both as topicals, layer GHK-Cu first and PDRN second. if you are using Rejuran injections, keep topicals at least 24 hours apart from injection day to let the injection sites settle.
PDRN has stronger evidence for wrinkle depth reduction because it is injected directly into the dermis (the active layer of your skin under the surface). GHK-Cu works well topically and has more decades of research behind it. for practical anti-aging on a budget, GHK-Cu serum is the easier entry point. for deeper texture correction and crow's feet, PDRN injections have shown phase III trial wins against hyaluronic acid filler, but require clinic visits and a budget of several hundred dollars per session.
the most common side effects are mild redness, swelling, or small bumps at injection sites that usually resolve within a day or two. bruising is rare but can last up to two weeks if it happens. if you have a diagnosed salmon allergy, you should not use PDRN because trace amounts of the source material may remain even after purification. topical PDRN serums are generally well-tolerated, but the injectable format requires a trained practitioner.
references
- Squadrito F, et al. "Pharmacological activity and clinical use of PDRN." Front Pharmacol. 2017;8:224. PMC5405115
- Marques C, Porcello A, Cerrano M, et al. "From Polydeoxyribonucleotides (PDRNs) to Polynucleotides (PNs): Bridging the Gap Between Scientific Definitions, Molecular Insights, and Clinical Applications of Multifunctional Biomolecules." Biomolecules. 2025;15(1):148. PMID 39858543
- Veronesi F, Dallari D, Sabbioni G, et al. "Polydeoxyribonucleotides (PDRNs) From Skin to Musculoskeletal Tissue Regeneration via Adenosine A2A Receptor Involvement." J Cell Physiol. 2017;232(9):2299-2307. PMID 27791262
- Galeano M, Pallio G, Irrera N, et al. "Polydeoxyribonucleotide: A Promising Biological Platform to Accelerate Impaired Skin Wound Healing." Pharmaceuticals (Basel). 2021;14(11):1103. PMC8618295
- Pickart L, Margolina A. "Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data." Int J Mol Sci. 2018;19(7):1987. PMID 29986520
- Pak CS, Lee J, Lee H, et al. "A phase III, randomized, double-blind, matched-pairs, active-controlled clinical trial and preclinical animal study to compare the durability, efficacy and safety between polynucleotide filler and hyaluronic acid filler in the correction of crow's feet: a new concept of regenerative filler." J Korean Med Sci. 2014;29(Suppl 3):S201-S209. PMID 25473210
- US Food and Drug Administration. "List of approved biologics and cosmetic products." FDA.gov, accessed april 2026. Rejuran (polynucleotide injectable, PN-HPT) not listed among approved aesthetic injectables as of this date.
- Lee KWA, Chan KWL, Lee A, et al. "Polynucleotides in Aesthetic Medicine: A Review of Current Practices and Perceived Effectiveness." Int J Mol Sci. 2024;25(15):8224. PMC11311621